Overview Alnylam Pharmaceuticals is seeking an imaginative physician drug developer, with the flexibility and confidence to work across diseases within the neurology and hematology therapeutic area. This role includes the opportunity to provide clinical leadership in developing RNAi therapeutics in Alnylam's expanding portfolio, which spans from rare genetic to common diseases. The successful candidate's primary role will be one of the clinical study leads working on the plasminogen program transitioning from Phase 2 to Phase 3. The Director will report directly into the program clinical development strategy lead who provides the clinical research oversight of the program. The Director is expected to play a leading and influencing role in the overall clinical development strategies and drive progress and operational excellence of his/her clinical trial(s). This work will also involve extensive consultation and collaboration with external experts. The Director, Clinical Research, will work in a matrix organization across Regulatory, Biostatistics, Clinical Operations, Preclinical, Commercial
Director, Clinical Research- Benign Hematology employer: Alnylam
Alnylam Pharmaceuticals is an exceptional employer, offering a dynamic hybrid work environment in Maidenhead that fosters innovation and collaboration. With a strong commitment to employee growth, our people-first culture prioritises inclusivity and excellence, ensuring that every team member can thrive while contributing to groundbreaking RNAi therapeutics. Recognised as a top biopharma employer globally, we provide meaningful opportunities for professional development and a supportive atmosphere where diverse perspectives are valued.
